GB202108231D0 - Treatment of disorders associated with low bh4 bioavaliability - Google Patents
Treatment of disorders associated with low bh4 bioavaliabilityInfo
- Publication number
- GB202108231D0 GB202108231D0 GBGB2108231.8A GB202108231A GB202108231D0 GB 202108231 D0 GB202108231 D0 GB 202108231D0 GB 202108231 A GB202108231 A GB 202108231A GB 202108231 D0 GB202108231 D0 GB 202108231D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- bioavaliability
- treatment
- low
- disorders associated
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108231.8A GB202108231D0 (en) | 2021-06-09 | 2021-06-09 | Treatment of disorders associated with low bh4 bioavaliability |
| JP2023537676A JP2024502252A (ja) | 2020-12-21 | 2021-12-21 | 低ｂｈ４バイオアベイラビリティーと関連する障害の処置 |
| AU2021406035A AU2021406035A1 (en) | 2020-12-21 | 2021-12-21 | Treatment of disorders associated with low bh4 bioavailability |
| CN202180087165.5A CN116723842A (zh) | 2020-12-21 | 2021-12-21 | 与低bh4生物利用度相关的病症的治疗 |
| MX2023007167A MX2023007167A (es) | 2020-12-21 | 2021-12-21 | Tratamiento de trastornos asociados a una baja biodisponibilidad de tetrahidrobiopterina (bh4). |
| IL303773A IL303773A (en) | 2020-12-21 | 2021-12-21 | Treatment of diseases associated with low bioavailability of BH4 |
| EP21839631.5A EP4262806A1 (en) | 2020-12-21 | 2021-12-21 | Treatment of disorders associated with low bh4 bioavailability |
| KR1020237024218A KR20230124967A (ko) | 2020-12-21 | 2021-12-21 | 낮은 bh4 생체 이용률과 관련된 장애의 치료 |
| PCT/GB2021/053382 WO2022136851A1 (en) | 2020-12-21 | 2021-12-21 | Treatment of disorders associated with low bh4 bioavailability |
| CA3202619A CA3202619A1 (en) | 2020-12-21 | 2021-12-21 | Treatment of disorders associated with low bh4 bioavailability |
| CL2023001821A CL2023001821A1 (es) | 2020-12-21 | 2023-06-19 | Tratamiento de trastornos asociados a una baja biodisponibilidad de bh4. |
| CONC2023/0008648A CO2023008648A2 (es) | 2020-12-21 | 2023-06-29 | Tratamiento de trastornos asociados con baja biodisponibilidad de bh4 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108231.8A GB202108231D0 (en) | 2021-06-09 | 2021-06-09 | Treatment of disorders associated with low bh4 bioavaliability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202108231D0 true GB202108231D0 (en) | 2021-07-21 |
Family
ID=76838766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2108231.8A Ceased GB202108231D0 (en) | 2020-12-21 | 2021-06-09 | Treatment of disorders associated with low bh4 bioavaliability |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN116723842A (zh) |
| GB (1) | GB202108231D0 (zh) |
-
2021
- 2021-06-09 GB GBGB2108231.8A patent/GB202108231D0/en not_active Ceased
- 2021-12-21 CN CN202180087165.5A patent/CN116723842A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN116723842A (zh) | 2023-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262608A (en) | Combined treatment of eye disorders and inflammatory diseases | |
| EP3914231A4 (en) | TREATMENT OF SKIN DISEASES WITH TOPICAL TAPINAROF COMBINATION COMPOSITIONS | |
| EP3618824A4 (en) | USE OF N-ACETYLCYSTONE FOR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | |
| GB201907283D0 (en) | Use of cannabidiol in the treatment of epileptic spams | |
| IL275499A (en) | Methods for treating metabolic disorders with FGF21 variants | |
| IL280765A (en) | Use of rolperidone to treat negative symptoms and disorders, to increase neural flexibility and promote neural protection | |
| EP3897641C0 (en) | TREATMENT OF MOVEMENT DISORDERS | |
| IL270900A (en) | Treatment of skin disorders | |
| GB202104868D0 (en) | Treatment of autism and autism spectrum disorders with biotin compositions | |
| IL281729A (en) | Low-intensity therapy with CPX-351 for hematologic disorders | |
| EP4069847A4 (en) | TREATMENT OF LOWER RESPIRATORY DISEASES | |
| GB201914034D0 (en) | Treatment of neurological disorders | |
| SI3049100T1 (sl) | Modificirani faktorji rasti fibroblasta-1 za zdravljenje očesnih motenj | |
| GB202015959D0 (en) | Treatment of diseases involving NAD | |
| IL283263A (en) | Treatment of skin diseases using electrolytic water | |
| IL304628A (en) | Treatment of skin disorders | |
| GB202108231D0 (en) | Treatment of disorders associated with low bh4 bioavaliability | |
| IL290619A (en) | rms treatment by switching treatment | |
| IL282869A (en) | Use of tibozenib to treat patients with resistant cancer | |
| GB202020285D0 (en) | Treatment od disorders associated with loww BH4 bioavailablility | |
| LT4225291T (lt) | Cholangiopatijų gydymas seladelparu | |
| SG11202007642RA (en) | Treatment of disorders with tasimelteon | |
| IL289012A (en) | Treatment of central nervous system disorders characterized by sleep disorders | |
| GB201908665D0 (en) | Treatment of cognitive disorders | |
| IL312434A (en) | Mesenchymal stem cells for the prevention and targeted treatment of cancer and other diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |